Aerobic Exercise
Behavioral180 minutes of moderate-vigorous intensity aerobic exercise per week
NCT Number: NCT03734146
We compared the effects of 8 weeks of aerobic exercise only, resistance exercise only, or a combination of both on blood pressure in overweight or obese middle-aged adults with elevated blood pressure. Participants engaged in supervised exercise sessions 3 times per week for 60 minutes each session. Outcomes were assessed at baseline and after the 8-week intervention. Extra-intervention physical activity and diet were also assessed.
Looking for future studies?
Notify Me45 year–74 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
180 minutes of moderate-vigorous intensity aerobic exercise per week
180 minutes of resistance exercise per week
180 minutes of exercise per week with 90 minutes per week coming from moderate-vigorous intensity aerobic exercise and 90 minutes per week coming from resistance exercise
Time frame: Immediately before and after the 8 week intervention
resting systolic and diastolic blood pressure
Iowa State University
Other
Acronym: ART-B
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03558893
Cardiovascular Diseases, Cardiovascular Risk Factor
Portland, Oregon, United States
View Trial DetailsNCT03039023
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT04731363
Cardiovascular Risk Factor
Cleveland, Ohio, United States
View Trial DetailsNCT03336255
Cardiovascular Risk Factor
Chicago, Illinois, United States
View Trial Details